Dr. Joshua Paul Spanogle, MD

Dr. Spanogle practices at Coastal Family Dermatology in San Luis Obispo, California.

Dr. Spanogle's NPI, 1750564407, was assigned on December 17, 2007. Dr. Spanogle graduated from Stanford University School Of Medicine in 2007. Dr. Spanogle holds California license A116055.

Dr. Spanogle's primary practice is Coastal Family Dermatology, at 892 Aerovista Pl, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 544-5567.

Dr. Spanogle's primary practice is Coastal Family Dermatology in San Luis Obispo, California. The medical group on file is Coastal Family Dermatology. Dmand AI also links Dr. Spanogle to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spanogle practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Spanogle's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Spanogle is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Spanogle's licenses on file in 6 states: California, Florida, Nevada, Ohio, Wyoming and Minnesota.

CMS data shows 354 Medicare services from Dr. Spanogle across 6 procedure codes in 2024, for 165 Medicare patients. Medicare paid $146,649 for them. Every service was in an office.

CMS counts 165 Medicare patients who saw Dr. Spanogle in 2024. The largest group is 65 to 74, with 81 patients. 72% of them have high cholesterol, and 56% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spanogle's median patient age at 74, with 45% women.

In 2024, Dr. Spanogle wrote 12 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. They cover 2 drugs, with $439 in total drug cost. In 2020, CMS named 230 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Spanogle for performance year 2024, reported as part of a group. Dr. Spanogle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 88 procedures of melanoma (skin cancer) excision by Dr. Spanogle, more than 92% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Spanogle, published from 2005 to 2021. The most frequent topics are Biocompatible Materials, Chemokine CCL2 and Interleukin-1. Dr. Spanogle has published most often in J Am Acad Dermatol. Dr. Spanogle's most frequent co-authors are Stuart Barry Goodman, MD, PhD, Austin Ambur, DO and William E. Bragg, MD.

CMS Open Payments shows 21 general payments to Dr. Spanogle from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $313.

Dmand AI lists 2 awards for Dr. Spanogle, most recently CMS Stage 1 EHR in 2013.

Dr. Spanogle graduated from Stanford University School Of Medicine in 2007. Dr. Spanogle is a member of AAD and American College of Mohs Surgery.

Dr. Spanogle is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.